Evidence map›Paper›PMID 23200504›Full record

ReviewLancet (London, England)2012

Prediction and prevention of the next pandemic zoonosis.

Stephen S Morse, Jonna A K Mazet, Mark Woolhouse, Colin R Parrish, Dennis Carroll, William B Karesh, Carlos Zambrana-Torrelio, W Ian Lipkin, Peter Daszak

Abstract readReview
In one paragraph

Review in Lancet (London, England), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 482 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
482citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

482 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

422 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Stephen S MorseMailman School of Public Health, Columbia University, New York, NY, USA.
Jonna A K Mazet
Mark Woolhouse
Colin R Parrish
Dennis Carroll
William B Karesh
Carlos Zambrana-Torrelio
W Ian Lipkin
Peter Daszak

Funding

Viral Pathogenesis and TherapeuticsU54AI057158 · NIAID · WADSWORTH CENTER · PI LIPKIN, W. IAN · 2003 to 2014
$100.8M
The Ecology, Emergence and Pandemic Potential of Nipah virus in BangladeshR01TW005869 · FIC · WILDLIFE TRUST · PI DASZAK, PETER · 2002 to 2012
$5.5M
Structural Controls of Functional Receptor and Antibody Binding to Viral Capsids.R01AI092571 · NIAID · CORNELL UNIVERSITY · PI PARRISH, COLIN R. · 2011 to 2021
$4.0M
Risk of Viral Emergence from BatsR01AI079231 · NIAID · ECOHEALTH ALLIANCE, INC. · PI DASZAK, PETER · 2008 to 2012
$2.6M
Modeling Anthropogenic Effects in the Spread of Infectious DiseasesR01GM100471 · NIGMS · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI PERRINGS, CHARLES · 2011 to 2014
$1.5M
FIC NIH HHS 2R01-TW005869FIC NIH HHS R01 TW005869NIAID NIH HHS AI079231NIAID NIH HHS AI57158NIAID NIH HHS R01 AI079231NIAID NIH HHS R01 AI092571NIAID NIH HHS U54 AI057158NIGMS NIH HHS R01 GM100471Wellcome Trust
6 · The paper itself

Abstract

Most pandemics--eg, HIV/AIDS, severe acute respiratory syndrome, pandemic influenza--originate in animals, are caused by viruses, and are driven to emerge by ecological, behavioural, or socioeconomic changes. Despite their substantial effects on global public health and growing understanding of the process by which they emerge, no pandemic has been predicted before infecting human beings. We review what is known about the pathogens that emerge, the hosts that they originate in, and the factors that drive their emergence. We discuss challenges to their control and new efforts to predict pandemics, target surveillance to the most crucial interfaces, and identify prevention strategies. New mathematical modelling, diagnostic, communications, and informatics technologies can identify and report hitherto unknown microbes in other species, and thus new risk assessment approaches are needed to identify microbes most likely to cause human disease. We lay out a series of research and surveillance opportunities and goals that could help to overcome these challenges and move the global pandemic strategy from response to pre-emption.

Indexed as

AnimalsBlood-Borne PathogensCommunicable Diseases, EmergingEnvironmental MonitoringGlobal HealthHealth PolicyHumansInternational CooperationPandemicsTravelVirus DiseasesZoonoses

Identifiers

PMID23200504
PMCPMC3712877

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.